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ABSTRACT
Histone chaperones are thought to be important for
maintaining the physiological activity of histones;
however, their exact roles are not fully understood.
The physiological function of template activating
factor (TAF)-I, one of the histone chaperones, also
remains unclear; however, its biochemical proper-
ties have been well studied. By performing microar-
ray analyses, we found that TAF-I stimulates the
transcription of a sub-set of genes. The transcrip-
tion of endogenous genes that was up-regulated by
TAF-I was found to be additively stimulated by
histone acetylation. On performing an experiment
with a cell line containing a model gene integrated
into the chromosome, TAF-I was found to stimulate
the model gene transcription in a histone chaperone
activity-dependent manner additively with histone
acetylation. TAF-I bound to the core histones and
remodeled the chromatin structure independent of
the N-terminal histone tail and its acetylation level
in vitro. These results suggest that TAF-I remodel
the chromatin structure through its interaction with
the core domain of the histones, including the
histone fold, and this mechanism is independent
of the histone acetylation status.
INTRODUCTION
Chromatin remodeling is a crucial step prior to transcription
initiation. Various chromatin regulatory factors have been
identiﬁed. ATP-dependent chromatin remodeling (ADCR)
complexes and histone modiﬁcation enzymes, such as histone
acetyltransferases (HATs) and deacetylases (HDACs) are asso-
ciated with the dynamic regulation of the chromatin structure
and gene activity (1). The cooperative function of these two
groups is well documented (2). For instance, SWI/SNF, an
ATP-hydrolyzing factor of the ADCR complexes, is recruited
to the gene promoter region through the recognition of
acetylated histones, and it sequentially promotes alteration
of the nucleosome structure (3). In addition to these two
groups, the histone chaperone family is also involved in
chromatin regulation and histone metabolism (4). In vitro
studies have demonstrated that histone chaperones bind to
core histones and facilitate assembly and disassembly of the
nucleosome structure in an ATP-independent manner. Nucleo-
some assembly protein-1 (NAP-1), one of the best-
characterized histone chaperones, facilitates assembly and
disassembly of nucleosomes containing both canonical and
variant histones in vitro (5,6). It is reported that NAP-1 facili-
tates disassembly of nucleosome in concert with ADCR and
histone acetylation in vitro (7,8). However, there exists little
information on the physiological role of histone chaperones
and their cooperative function with ADCR complexes and/
or histone modiﬁcations.
By using the adenovirus (Ad) chromatin-like genome
(Ad core) as a template, we found that template activating
factor (TAF)-I, a histone chaperone, acts as a stimulatory
factor for in vitro adenovirus DNA replication (9). Two iso-
forms exists, namely, TAF-Ia and TAF-Ib, and these form
homo- or hetero-dimers through their dimerization domain
(10). TAF-Ib is encoded by the putative oncogene SET
(11). TAF-I is implicated in the regulation of several cellular
processes including mRNA stability, cell-cycle regulation,
signal transduction and apoptosis (12–16). We demonstrated
that TAF-I has histone chaperone activity (17,18). Dimeriza-
tion and the acidic amino acid cluster are essential for the
histone chaperone activity and the stimulation of Ad core
DNA replication in vitro (10,17,18). TAF-I stimulates the
cell-free transcription from the cellular-type chromatin tem-
plate in vitro (17). Thus, it is quite possible that TAF-I
plays a basic role in the assembly and disassembly of the
cellular chromatin structure and the regulation of gene activ-
ity. It is indicated that TAF-I is a component of an inhibitor
of the histone acetyltransferse complex (INHAT) (19). In
addition, TAF-I interferes with the DNA binding of transcrip-
tion factors, such as Sp1 and KLF5, and thereby represses
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TAF-I, it has been demonstrated that TAF-Ib is involved in
the stimulation of Hoxa9 and KAI1 gene transcription
(22,23). It is also reported that TAF-I augments the transcrip-
tional activity of CBP, a HAT/co-activator protein (24).
When considered together, these results suggest that TAF-I
may regulate transcription positively or negatively in a
gene-speciﬁc manner, possibly in concert with histone
acetylation. However, the molecular mechanism of the
gene-speciﬁc function of TAF-I and the functional interaction
between TAF-I and histone modiﬁcations are not well under-
stood.
Here, we have addressed the mechanism of transcription
stimulation by TAF-I in concert with histone acetylation.
cDNA microarray analyses demonstrated that TAF-I is
involved in the positive or negative transcription regulation
of a sub-set of genes. The transcription regulation of genes
regulated by TAF-I is independent of the level of histone
acetylation. Furthermore, TAF-I stimulated transcription
from a model gene is integrated in the chromosome in a
histone chaperone activity-dependent manner, but indepen-
dently of the histone acetylation level. Consistent with this
ﬁnding, we found that the histone N-terminal tail is not
required for the histone chaperone activity of TAF-I.
MATERIALS AND METHODS
Cell cultures
Monolayer cultures of HeLa cells and WT (clone 7) and
TAF-I KD (clone 4) HeLa cell lines (25) were maintained
at 37 C in the minimal essential medium (MEM; Nissui)
containing 10% FBS. CHO-AA8-Luc Tet-Off control cell
line (CHO-luc) (CLONTECH) was maintained at 37 Ci n
the minimum essential alpha medium (a-MEM; GIBCO)
containing 10% FBS. In CHO-luc cells, the luciferase gene
transcription is regulated by a tetracycline-responsive VP16
fusion activator (TetR-VP16) (26). In order to investigate
the effect of TAF-Ib under the condition where the luciferase
expression does not reach the saturation level, we set
the tetracycline concentration (1 mg/ml) so as to keep the
luciferase expression at the basal level.
Plasmid DNAs and recombinant proteins
Plasmid DNAs, pCAGGS, an eukaryotic expression vector
(27), pCHA-TAF-Ib and pCHA-TAF-IbDC3, were prepared
as described previously (22). To generate pCHA-TAF-
IbPME for expression of TAF-Ib containing point mutants
in its dimerization domain, a DNA fragment was prepared
by digestion of pET-14bTAF-IbPME plasmid DNA (10)
with NdeI and BamHI. The cohesive ends of this fragment
were treated with Klenow fragment to be blunt and ligated
into MluI-digested pCHA, the ends of which had also been
ﬁlled with Klenow fragment. Hexa-histidine- (His-) tagged
TAF-Ib, TAF-IbDC3 and TAF-IbPME were prepared as
described previously (10).
Antibodies
Antibodies used in this study are as follows: For TAF-Ia and
b, mouse anti-TAF-I monoclonal antibody (KM1726) and for
TAF-Ib, mouse monoclonal antibody (KM1720) (28); for
experimental control of ChIP, mouse anti-Flag (M2)
monoclonal antibody; for Hsp90, rabbit polyclonal antibody
[kindly provided by Drs Miyata Y. and Nishida E.
(Kyoto University)] (29); for TBP, rabbit polyclonal antibody
(Santa Cruz); for HA-tag, rat monoclonal (3F10) antibody
(Roche), for histone H3, rabbit polyclonal antibody (abcam);
for acetylated histone H3 (K9, K14), rabbit polyclonal anti-
body (Upatate); for histone H4, rabbit polyclonal antibody
(abcam); for acetylated histone H4 (K5), rabbit polyclonal
antibody (abcam).
Microarray analyses
Total RNA was isolated from WT and TAF-I KD HeLa cell
lines using the guanidine method (30). The concentration
of RNA in each sample was determined using a spectropho-
tometer. The RNA was processed and hybridized to the Code
Link  human whole genome array, according to the manu-
facture’s protocols (GE Healthcare). Chips were scanned
and analyzed using Microarray software (arrayWoRx
e).
RT–PCR
WT and TAF-I KD HeLa cells were treated without or with a
HDAC inhibitor, trichostatin A (TSA) at the concentration of
0.1 mM for indicated periods. cDNA was synthesized from
the total RNA (2 mg) using Superscript III reverse transcrip-
tase (RT; Invitrogen) and oligo-dT primer. PCR was
performed using synthesized cDNAs and a set of speciﬁc
primers complementary to human AKAP12, KRT17,
TFAP2C, SERPINI1, cTnC, b-actin, and RPL13A (31)
mRNAs by pre-determined PCR cycles under which PCR
products are logarithmically ampliﬁed. Primer sequences
were as follows: AKAP12 forward direction, 50-GGGACCA-
TCACCATCACAG-30; AKAP12 reverse direction, 50-CAGT-
GAGTAGCTGGACAGTG-30; KRT17 forward direction, 50-
GAGGATTGGTTCTTCAGCAAG-30; KRT17 reverse direc-
tion, 50-TCACATCCAGCAGGATTTTGTA-30; TFAP2C for-
ward direction, 50-GGCCCAGCAACTGTGTAAAGA-30;
TFAP2C reverse direction, 50-GCAGTTCTGTATGTTCGT-
CTCCAA-30; SERPINI1 forward direction, 50-GGATTTTG-
ATGCTGCCACTTATC-30; SERPINI1 reverse direction;
50-TTTGGACTTCACTTTCATCATCTTTAG-30; cTnC for-
ward direction, 50-GTAGAGCAGCTGACAGAAG-30; cTnC
reverse direction, 50- TTGTCAAACATGCGGAAGAG-30;
b-actin forward direction, 50-ATGGGTCAGAAGGATTCC-
TATGT-30; b-actin reverse direction, 50-GGTCATCTTCTC-
GCGGTT-30; RPL13A forward direction, 50-CATCGTGGC-
TAAACAGGTACTG-30; and RPL13A reverse direction, 50-
GCACGACCTTGAGGGCAGCC-30. The PCR products
were separated on a 6% PAGE, visualized by staining with
EtBr, and quantiﬁed with NIH Image.
Luciferase assay
CHO-luc cells transfected with plasmid DNAs where
indicated were washed with phosphate-buffered saline
(PBS) and lysed in a cell lysis buffer [25 mM Tris–HCl
(pH 7.9), 10% Glycerol and 0.1% Triton X-100] by ﬁve
freezing-thawing cycles. The cell lysates and a luciferase sub-
strate (Promega) were mixed, and the luciferse activity was
measured by Lumat LB9506 (BERTHOLD). Transfection
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(Mirus).
Chromatin immunoprecipitation (ChIP)
HeLa cells were ﬁxed with 1% formaldehyde at room
temperature for 10 min, and ChIP was carried out essentially
according to the protocol from Upstate Biotechnology using
antibodies where described. The recovered DNA was ampli-
ﬁed by PCR with the primer sets. Primer sequences used were
as follows: b-actin promoter forward direction, 50-ATGCTG-
CACTGTCGGCGAAG-30; b-actin promoter reverse direc-
tion, 50-ATCGGCAAAGGCGAGGCTCT-30; cTnC promoter
forward direction, 50-TATGAGCTTGGCATTCGAGGCTT-
30; and, cTnC promoter reverse direction, 50-TGACCTCCAC-
TTTCCAGATAAGG-30. Transfected CHO-luc cells were
ﬁxed with 1% formaldehyde at room temperature for 10 min,
and ChIP was carried out. A primer set, 50-CTCGGTAC-
CCGGGTCGAGTAG-30 and 50-CCGCGGAGGCTGGATC-
GGT-30, was used to amplify the human cytomegarovirus
(HCMV) minimal promoter region which directs transcrip-
tion of the integrated luciferase gene. The PCR products
were separated on a 6% PAGE, visualized by staining
with EtBr, and quantiﬁed with NIH Image.
Chromatin reconstitution and micrococcal nuclease
(MNase) digestion assay
Chromatin was reconstituted on a plasmid DNA, pUC119-
ML2, with core histones prepared from mock-treated cells,
hyperacetylated core histones prepared from cells treated
with sodium n-butyrate (NaBu), a HDAC inhibitor (32),
and tail-less core histones by the salt dialysis method as
described previously (17). To generate pUC119-ML2, a
DNA fragment containing the region between nucleotide
position 4979 and 6242 (where the left terminus of ade-
novirus type 2 DNA is deﬁned as position 1) was excised
from pSmaF (33) by digestion with PstI and HindIII and
cloned into PstI and HindIII-digested pUC119. Reconstituted
chromatin (50 ng DNA) was subjected to partial digestion
with MNase in a digestion buffer [10 mM Tris–HCl (pH
7.9), 70 mM NaCl, 3 mM CaCl2 and 1.5 mM MgCl2]a t
37 C. Digested DNA was puriﬁed, separated by 1.4% agarose
gel electrophoresis, and visualized by SYBR Gold (Molecular
probe) staining.
RESULTS
Involvement of TAF-I in the transcription regulation
in vivo
It has been reported that TAF-I is involved in the expression
of various genes. We attempted to conﬁrm this using the
microarray technique and TAF-I knock-down (KD) cells.
Previously, we had established stable HeLa cell lines in
which the expression of TAF-I was knocked down by
siRNA (25). Here, we used one of the TAF-I KD cell lines,
in which the expression levels of the proteins TAF-Ia and
TAF-Ib were reduced to  10% relative to that of the wild-
type cell (WT) (Figure 1A). Comparison of the gene expres-
sion proﬁle of TAF-I KD with that of WT cells by microarray
analysis indicated that several genes are down-regulated or
up-regulated due to the reduction of the expression level of
TAF-I, suggesting that TAF-I stimulates and represses sub-
sets of genes. Among the 29172 array probes that
we tested, we detected 106 probes that showed more than a
2-fold down-regulation in the signal and 48 probes that
showed more than a 2-fold up-regulation in the signal. We
selected genes that were well annotated, and summarized
the results (Supplementary Table 1). We conﬁrmed the
mRNA expression level of some of the genes by using
semi-quantitative RT–PCR (Figure 1B, and data not
shown). Figure 1B shows the RT–PCR result which indicates
that AKAP12 and KRT17 are the down-regulated genes and
TFAP2C and SERPINI1 are the up-regulated genes. This sug-
gests that the alteration pattern of these genes matches well
with the results of the microarray analysis. To study the posi-
tive function of TAF-I, we decided to focus on certain down-
regulated genes in the TAF-I KD cells. Among the genes
examined so far, the slow/cardiac troponin C (cTnC) gene
(34) was observed to be one of the typical genes whose
expression level was drastically reduced in the TAF-I KD
cells (Figure 1C). To examine whether TAF-Ib is associated
with the cTnC gene promoter, we performed ChIP assays by
using an antibody against TAF-Ib (Figure 1D). TAF-Ib inter-
acted with the cTnC promoter but not the b-actin promoter
region, suggesting that TAF-I regulates the cTnC gene
expression at the level of transcription by binding to the
promoter region.
TAF-I stimulates the model gene transcription in a
histone chaperone activity-dependent manner
By microarray analyses, we found that TAF-I stimulates the
transcription of a sub-set of genes, such as cTnC. Further, to
quantitatively analyze the effect of TAF-I on the transcription
from the chromatin template, we exploited the properties of
the cell line CHO-luciferase (CHO-luc); in CHO-luc the
model reporter gene is integrated in the chromosome such
that the luciferase gene transcription is regulated in the con-
text of the chromatin structure. By using this system, we
found that the luciferase expression is stimulated by TAF-
Ib in a dose-dependent manner (Figure 2A and B). We
did not detect the TAF-I-dependent transcription stimulation
when the luciferase reporter plasmid was transiently co-
transfected with a TAF-I expression vector (data not
shown), indicating that TAF-I-dependent stimulation is
speciﬁc for the gene integrated in the chromosome.
To examine whether this stimulatory effect of TAF-I is
dependent on its histone chaperone activity, we prepared
histone chaperone activity-deﬁcient TAF-Ib mutants
(Figure 2A–C). Since the acidic amino acid cluster and
dimerization of TAF-I are essential for the remodeling of
the Ad core and histone chaperone activity, we used two
mutants -one lacking the C-terminal acidic amino acid cluster
region, termed TAF-IbDC3, and the other containing point
mutations in the coiled-coil dimerization domain, termed
TAF-IbPME (10,11). The acidic amino acid cluster is essen-
tial for the INHAT activity, while dimerization of TAF-Ib is
not completely required (19). In contrast, neither the acidic
amino acid cluster nor the dimer formation is essential for
the I2PP2A activity of TAF-Ib (16). These suggest that the
dimerization domain is crucial for the maximal chaperone
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activities. In contrast to TAF-Ib WT (wild-type), neither
TAF-IbDC3 nor TAF-IbPME stimulated luciferase expres-
sion, suggesting that the stimulation of the luciferase gene
transcription is dependent on the histone chaperone activity
of TAF-Ib. Next, we examined the chromatin remodeling
activity of TAF-Ib, and compared this activity of TAF-Ib
WT with that of each TAF-Ib mutant by using the nuclease
sensitivity assay that employed recombinant His-tagged
TAF-Ib derivatives (Figure 2D and E) (10). The chromatin
structure was reconstituted using puriﬁed cellular core
histones on a plasmid DNA in vitro (17). After incubation
with each TAF-Ib protein, the reconstituted chromatin was
subjected to nuclease sensitivity assays by using micrococcal
nuclease (MNase). While the reconstituted chromatin was
highly insensitive to digestion by MNase, TAF-Ib WT
enhanced the nuclease sensitivity of the reconstituted
chromatin (Figure 2E, compare lanes 2–4 and 5–7); this
was in good agreement with the previous report, which stated
that TAF-Ib WT efﬁciently remodels the chromatin structure
(17). In contrast, the nuclease sensitivity of chromatin was
slightly induced by TAF-IbPME (Figure 2E, compare lanes
5–7 and 11–13). The nuclease sensitivity was not signiﬁ-
cantly induced by TAF-IbDC3 (Figure 2E, lanes 8–10),
while TAF-IbDC3 showed slightly higher activity than
TAF-Ib PME. These results suggest that the chromatin
remodeling activity of TAF-Ib is dependent on both dimer
formation and the acidic cluster region. It is likely that the
hydrophilic surface of the dimerized coiled-coil region has
a slight chromatin remodeling activity as shown by the
experiments using the Ad core (35). When these results
are considered together, it may be suggested that TAF-Ib
Figure 1. Involvment of TAF-I in the cTnC transcription in HeLa cells. (A) The level of TAF-I in TAF-I KD HeLa cell lines. Cell extracts prepared from WT
(clone 7) and TAF-I KD (clone 4) cells were separated by a 10% SDS–PAGE, and TAF-I proteins and Hsp90 for a loading control were detected by
immunoblotting with anti-TAF-I (KM1726) (upper panel) and anti-Hsp90 (lower panel) antibodies, respectively. (B) Semi-quantitative RT–PCR for endogenous
genes. Total RNA was isolated from WT and TAF-I KD cell lines and analyzed by RT–PCR for semi-quantitative detection of transcripts from the b-actin,
AKAP12, KRT17, TFAP2C and SERPINI1 genes. cDNAs were synthesized without (lanes 1 and 3) and with (lanes 2 and 4) the reverse transcription. PCR
products amplified by 23, 25 and 27 PCR cycles for the AKAP12, 24, 26 and 28 PCR cycles for the KRT17, 26, 28 and 30 PCR cycles for the TFAP2C and the
SERPINI1, and 20, 22 and 24 PCR cycles for the b-actin, respectively, were loaded onto a 6% polyacrylamide gel. After separation, PCR products were
visualized by staining with EtBr. (C) Semi-quantitative RT–PCR of cTnC mRNA. Total RNA was isolated from WT and TAF-I KD cell lines and analyzed by
RT–PCR for semi-quantitative detection of transcripts from the b-actin and cTnC genes. cDNAs were synthesized without (lanes 1 and 2) and with (lanes 3 and
4) the reverse transcription. PCR products amplified by 26 and 28 PCR cycles for the b-actin, and 32 and 34 PCR cycles for the cTnC, respectively, were loaded
onto a 6% polyacrylamide gel. After separation, PCR products were visualized by staining with EtBr. The cTnC gene is mainly expressed and functions in cardiac
ventricle and slow skeletal muscle. The cTnC gene is also expressed but at the low level in HeLa cells, in which neither a biological meaning nor a regulatory
mechanism of the cTnC gene expression is yet known. (D) ChIP assay. Association of TAF-Ib with the cTnC gene in HeLa cells was examined by ChIP assays.
ChIP assays were performed with indicated antibodies. The anti-Flag tag antibody was used as a non-specific control antibody. Immunoprecipitated DNA was
amplified with PCR using a set of primers specific for the b-actin and the cTnC promoter regions. PCR products were analyzed by a 6% polyacrylamide gel, and
visualized by staining with EtBr. Input DNA was purified from 1/50 of cell lysates used for immunoprecipitation. The band intensity was quantitatively measured
with NIH image, and ratios (AcH3/H3 and TAF-Ib/Input) are shown. BG indicates that no differences were observed between values obtained with control
antibody and those with anti-TAF-Ib antibody.
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stimulates its transcription in CHO-luc cells.
Next, to determine whether over-expression of TAF-Ib
affects histone acetylation around the model gene promoter
region, we examined the histone acetylation level in the
model gene promoter region by ChIP assays. In CHO-luc
cells that over-express each TAF-Ib derivative, the amounts
and the acetylation levels of histone H3 and H4 were not
signiﬁcantly altered (Figure 3A). These results indicate that
TAF-Ib does not affect the histone acetylation of the model
gene promoter. Next, to determine whether TAF-Ib is associ-
ated with the model gene promoter region, we carried out
ChIP assays using a TAF-Ib antibody (Figure 3B). We nor-
malized the level of DNA that co-immunoprecipitated with
each TAF-Ib mutant by estimating the expression level
of each protein (Figure 3C and D). TAF-Ib WT was associ-
ated with the model gene promoter, while TAF-IbPME
showed lower efﬁciency with regard to this association as
Figure 2. Stimulation of the model gene transcription by TAF-I in the histone chaperone activity-dependent manner. (A) Luciferase assays. CHO-luc cells were
transiently transfected with indicated amounts of pCAGGS, pCHA-TAF-Ib, pCHA-TAF-IbDC3 and pCHA-TAF-IbPME, incubated in the presence of 1 mg/ml
tetracycline, and collected at 48 h post transfection. pCHA vector (28) was generated from a control vector by pCAGGS (27) so as to express an HA-tagged
protein. Cell lysates were prepared, and the luciferse expression was examined. The protein concentration of cell lysates was determined by the Bradford method,
and the luciferase activity was normalized by the protein concentration. Results are represented as mean values ± SDs from three independent experiments. (B)
The expression level of each HA-tagged TAF-I derivatives. Cell extracts (total amount of protein; 1.5 mg) prepared from CHO-luc cells transfected with each
amount of DNA for expression of TAF-I mutants [see (A), under the graph] were separated by a 10% SDS–PAGE, and each HA-tagged TAF-I protein was
detected by immunoblotting with anti-HA antibodies. Results of three independent experiments are shown. (C) Representation of relative transcription
stimulatory activities of TAF-Ib derivatives. The band intensity of each TAF-I derivatives (B) were quantitatively measured with NIH image. The luciferase
activity (A) was normalized by each protein expression level, and the relative activity is summarized, where the average of experiments using the TAF-Ib WT is
set as 1. Results are represented as mean values ± SDs from three independent experiments. (D) Purified recombinant proteins. Recombinant His-tagged TAF-Ib
(WT), TAF-IbDC3 (DC3), TAF-IbPME (PME) (400 ng each) generated in the bacterial expression system were purified according to the manufacture’s
instruction, separated by a 15% SDS–PAGE, and visualized by staining with Coomassie brilliant blue. Lane M shows molecular weight markers. (E) MNase
sensitivity assay. Reconstituted chromatin (50 ng DNA) was incubated at 30 C for 30 min without (lanes 1–4) or with His-tagged TAF-Ib (1.2 mg, lanes 5–7),
His-tagged TAF-IbDC3 (960 ng, lanes 8–10) and His-tagged TAF-IbPME (1.2 mg, lanes 11–13). The mixture was then subjected to partial digestion without
(lane 1) or with MNase (0.0003 U for lanes 2, 5, 8 and 11, 0.0015 U for lanes 3, 6, 9 and 12, 0.0075 U for lanes 4, 7, 10 and 13) at 37 C for 6 min. DNAs were
purified, separated by electrophoresis on a 1.4% agarose gel and visualized by SYBR Gold staining. Lane M shows DNA size markers. The nucleosome-derived
DNA ladders are shown by bullets.
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IbDC3 was also associated with the model gene promoter
with lower efﬁciency than TAF-IbWT (Figure 3B, lanes
10 and 11, and D). These results suggest that dimmer forma-
tion but not the acidic amino acid cluster of TAF-Ib is essential
for its association with chromatin. It is interesting to note that
the acidic cluster is not required for the chromatin binding of
TAF-I. In other words, the hydrophilic surface of the dimeriza-
tion domain would be important for the chromatin binding of
TAF-I. Nevertheless, it is concluded that the histone
chaperone/chromatin remodeling activity of TAF-I is impor-
tant for stimulation of the transcription of the model gene.
TAF-I and histone acetylation additively stimulates the
transcription
Next, we examined the effect of histone acetylation on the
model gene transcription stimulated by TAF-Ib (Figure 4).
CHO-luc cells expressing TAF-Ib WT were incubated with-
out or with increasing concentrations of TSA, a class I HDAC
inhibitor (36). The luciferase expression was stimulated by
the over-expressed TAF-Ib (1st and 2nd bars). The luciferase
expression was slightly stimulated by the addition of 3 nM of
TSA (1st and 3rd bars), signiﬁcantly stimulated in combina-
tion with over-expressed TAF-Ib (1st–4th bars), and greatly
stimulated by the addition of 10 nM of TSA (1st and 5th
bars). Under this condition however the over-expressed
TAF-Ib was not stimulatory (5th and 6th bars). The expres-
sion levels of both endogenous and exogenous TAF-Ib
were not affected by TSA treatment (Figure 4, upper
panel). These results indicate that the model gene transcrip-
tion is stimulated by TAF-Ib additively or slightly more
than additively with histone acetylation when the basal
transcription level of the model gene remains at a low
level. The stimulatory effect of TAF-Ib decreased when the
model gene transcription was sufﬁciently stimulated by a
high level of histone acetylation or the transcription activator
TetR-VP16 (data not shown). Based on these results, it is
presumed that TAF-I is associated with genes expressed at
an intrinsically low level. This possibility is supported by
the observation of the endogenous cTnC gene (Figure 1D),
since the transcription of the cTnC gene is maintained at a
low level in HeLa cells as compared with that in the cardiac
ventricle and slow skeletal muscle cells (34). We compared
the acetylation level of histone H3 and the amount of TBP
(TATA-binding protein) at the cTnC promoter with those at
Figure 3. Association of TAF-I with the model gene promoter. (A and B) ChIP assays. CHO-luc cells were transfected with 10 mg of pCAGGS (Mock), pCHA-
TAF-Ib (WT), pCHA-TAF-IbDC3 (DC3) and pCHA-TAF-IbPME (PME) plasmids. Cells were fixed with 1% formaldehyde at 48 h post transfection. Cell lysates
were prepared, and immunoprecipitation was performed with indicated antibodies. DNA was purified, and the HCMV minimal promoter region of the luciferase
gene was amplified by PCR using immunoprecipitated DNA as a template. PCR products amplified by 23, 25, 27 and 29 PCR cycles [(A); left panel and (B)],
and 26, 28 and 30 PCR cycles [(A); right panel] were analyzed by a 6% polyacrylamide gel and visualized by staining with EtBr. Input DNA was purified from
1/50 of cell lysates used for immunoprecipitation. (C) The expression level of each HA-tagged TAF-I mutant protein. Cell extracts (1/150 of the input for ChIP
assay) were separated by a 10% SDS–PAGE, and each HA-tagged TAF-I protein was detected by immunoblotting with anti-HA antibodies. Lane M shows
molecular weight markers. (D) Representation of the relative chromatin binding activity of TAF-Ib derivatives. The band intensity of each TAF-I derivatives
(C) was quantitatively measured with NIH image. The level of DNA co-immunoprecipitated with each TAF-I derivatives (B) was normalized by each protein
expression level, and the relative activity is summarized, where the average of experiments using TAF-Ib WT is set as 1.
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assays clearly demonstrated that both the acetylation level of
histone H3 and the amount of TBP at the cTnC promoter are
lower than those of the b-actin promoter (Figure 1D). These
results suggest that the transcription of the cTnC gene ossurs
at a basal level, and TAF-I may be involved in the basal
transcription step.
To conﬁrm this ﬁnding using the model gene, we examined
the effect of histone acetylation induced by TSA on the
transcription level of the endogenous cTnC gene in TAF-I
KD cells. If TAF-I functions as INHAT on the cTnC gene,
TSA may restore the cTnC transcription level in the KD
cells more efﬁciently than that in the WT cells. In contrast,
if TAF-I positively affects the HAT function, TSA may
restore the cTnC transcription level in the WT cells more
efﬁciently than that in the KD cells. Total RNA was prepared
from the cells incubated with TSA and subjected to semi-
quantitative RT–PCR (Figure 5A), and the results are summa-
rized in Figure 5B. In both WT and TAF-I KD cells, the cTnC
transcription was up-regulated during the incubation periods
in the presence of TSA, whereas the ribosomal protein
L13A (RPL13A) gene transcription remained unaltered (31).
The transcription level of the cTnC in the WT cells was
higher than that in the TAF-I KD cells at all time points,
suggesting that TAF-I functions positively in the cTnC
transcription. Furthermore, the stimulation proﬁles of both
WT and TAF-I KD cells were parallel, suggesting that the
cTnC gene transcription is stimulated by TAF-I additively
with histone acetylation.
Association of TAF-Ib with chromatin independent of
the histone acetylation level in vivo
It has been reported that TAF-Ib represses the EB1 gene
transcription in a manner similar to INHAT (37). In this
gene regulation, the association of TAF-Ib with the promoter
region is repressed by histone acetylation. By using the model
cell line, we have demonstrated that the transcription of
the model gene is stimulated by TAF-Ib additively with
histone acetylation. Since TAF-Ib stimulated the model
gene transcription independent of the level of histone acety-
lation, there is a high-possibility that the association of TAF-
Ib with the model gene is not affected by histone acetylation.
To conﬁrm this, we examined the amount of TAF-Ib
associated with the model gene promoter under various levels
of histone acetylation. By using antibodies against TAF-Ib
and acetylated histone H3, we performed ChIP assays with
CHO-luc cells that over-express TAF-Ib WT and were trea-
ted with TSA (Figure 6). The ChIP assays showed that the
amount of DNA co-immunoprecipitated with an antibody
against the acetylated histone H3 increased gradually with
the incubation periods in the presence of TSA (upper
panel). This indicates that the histones associated with the
model gene promoter are acetylated as a function of the
incubation time with TSA. In contrast, the amount of DNA
co-immunoprecipitated with an antibody against TAF-Ib
remained unaltered (lower panel). These results suggest that
TAF-Ib is associated with the model gene promoter indepen-
dent of the histone acetylation level.
Histone tail and the acetylation-independent histone
chaperone activity of TAF-I
Next, we examined whether acetylation of the histone
N-terminal tail affects the histone binding activity of TAF-Ib
Figure 5. Time course-dependent increase of the level of the cTnC mRNA by
TSA in WT and TAF-I KD cells. (A) WT and TAF-I KD cells were treated
with 0.1 mM of TSA and collected cells at indicated time points. Total RNA
was purified and analyzed by RT–PCR for semi-quantitative detection of
transcripts from the cTnC and the RPL13A genes. PCR products amplified by
28, 30 and 32 PCR cycles for cTnC, and 23, 25 and 27 PCR cycles for
RPL13A, respectively, were analyzed by a 6% polyacrylamide gel and
visualized by staining with EtBr. (B) The band intensity of the cTnC was
quantitatively measured with NIH image, and the relative average intensity
for the cTnC is summarized, where the level of the cTnC-derived RT–PCR
product in TAF-I KD at 0 h is set as 1.
Figure 4. Effects of over-expressed TAF-Ib and TSA. CHO-luc cells were
transiently transfected with 0.5 mg of pCAGGS ( ) or a combination of
0.4 mg of pCAGGS and 0.1 mg of pCHA-TAF-Ib (+). After the addition of
TSA at 24 h post transfection, cells were incubated further for 24 h, and the
luciferase expression was examined. The luciferase activity was normalized
by the protein concentration. Results are represented as mean values ± SD
from three independent experiments (lower panel). The level of endogenous
and exogenous TAF-Ib was examined with western blotting using an
anti-TAF-Ib antibody (upper panel).
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this, we prepared core histones (38) from mock-treated cells
(N-core histones) and from sodium n-butyrate (NaBu)-treated
cells (Ac-core histones) (Figure 7A). Sodium n-butylate is
a potent inducer of erythroid differentiation and a well-
known HDAC inhibitor (32). The core histones were co-
immunoprecipitated with His-tagged TAF-Ib under a
physiological salt concentration, and the amount of co-
immunoprecipitated core histone decreased as the salt con-
centration in the washing buffer increased (Figure 7B).
The level of Ac-core histones co-immunoprecipitated with
His-tagged TAF-Ib was similar to that of the N-core histones,
indicating that TAF-Ib binds to the core histones independent
of the histone acetylation level. Further, to conﬁrm this,
we prepared core histones devoid of the N-terminal tail
[tail-less core histones (TL-core histones)] by partial diges-
tion with trypsin (39). Immunoprecipitation assays demon-
strated that TAF-Ib binds to core histones, irrespective of
the presence or absence of the N-terminal tail (Figure 7B).
These results suggest that the histone N-terminal tail is
not required for the binding of TAF-Ib with the core histones.
These in vitro observations were consistent with the results
that TAF-Ib is associated with the model gene promoter
independent of the histone acetylation level (Figure 6).
Next, we examined the effect of the N-terminal tail of
histones and its acetylation on the chromatin disassembly
activity of TAF-Ib. In Figure 2E, we showed that TAF-Ib
remodels the chromatin structure depending on its acidic
cluster and dimer formation. The chromatin structure was
reconstituted in vitro by using puriﬁed N-, Ac- or TL-core
histones on a plasmid DNA (17), and the nucleosome struc-
ture was conﬁrmed by MNase digestion (Figure 7C). Then,
the reconstituted chromatin was subjected to nuclease
sensitivity assays using the restriction endonuclease PvuII
(Figure 7D and E). The nuclease sensitivity of the reconsti-
tuted chromatin was much lower than that of the naked
DNA (Figure 7E, lanes 3 and 5), and it increased upon
incubation with increasing amounts of TAF-Ib (Figure 7E,
lanes 5–7). The nuclease sensitivity of the chromatin recon-
stituted with Ac-core histones was slightly more sensitive
than that of the other reconstituted chromatin structures
(Figure 7E, lanes 5, 9 and 13). This is consistent with the
previous ﬁnding that hyperacetylated chromatin forms an
extended conformation as compared to the hypoacetylated
chromatin (40). The nuclease sensitivity of the chromatin
reconstituted with N-, Ac- and TL-core histones showed
equal increase in a TAF-Ib dose-dependent manner
(Figure 7E, lanes 5–7, 9–11 and 13–15). These results
indicate that TAF-Ib remodels the chromatin structure
irrespective of the histone tail and its acetylation.
DISCUSSION
Based on the result of the microarray analyses, we have
demonstrated that TAF-I is involved in transcription stimula-
tion and repression of gene sub-sets (Supplementary Table 1
and Figure 1B). Currently, we have not reached a consensus
on the mechanism of gene down-regulation in TAF-I KD
cells. However, it is noted that among the genes up-regulated
by TAF-I KD, TPD52L1, TFAP2C, DNAJC12 and TFF1
genes are reported to be estrogen-responsive (1,41–43). The
transcription of these genes was increased by estrogen in
the estrogen receptor (ER)-positive breast cancer cells, such
as MCF-7 cells. Hence, we propose that these estrogen-
responsive genes are repressed by TAF-I possibly through
its INHAT activity in the ER-negative cells such as HeLa
cells.
TAF-Ib stimulated transcription additively with histone
acetylation induced by the low but not the high-concentration
of HDAC inhibitors (Figure 4). Since the order of acetylation
of the various lysine residues in histones is not random (44),
it is possible that the initially acetylated sites make the
nucleosomal DNA more accessible to the remodeling factors
by facilitating a conformational transition of the nucleosome.
Consistent with this ﬁnding, it has been reported that the low
concentration of HDAC inhibitor causes local structural
changes of the nucleosomes and enhances the basal transcrip-
tion from the MMTV promoter independent of a hormone lig-
and, while the high-concentrations of inhibitors inhibits the
transcription (45). We demonstrated that TAF-Ib targets the
C-terminal histone fold domain rather than the N-terminal
histone tail of the histones in nucleosomes (Figure 7B and
E). It is possible that TAF-Ib contacts the DNA-wrapped
core region of this transcription-competent chromatin and
loosens the histone fold–DNA interaction independent of
histone acetylation, thereby promoting the formation of the
basal transcription machinery or attenuation of resumption
of the competent chromatin to the repressed chromatin struc-
ture. Once genes are sufﬁciently activated by forming the
loosened nucleosome structure, TAF-I may not be required.
We found that the MNase sensitivity is greatly increased at
the model gene promoter region in the CHO-luc cells after
incubation with 1 mM of TSA for 24 h (data not shown). It
is possible that histones are highly acetylated and most of
the histones might be removed from the promoter region,
so that a large amount of histone chaperone is not required.
Although we have focused on the transcription stimulatory
Figure 6. Effects of the histone acetylation level on associations of TAF-Ib
with the model gene chromatin. Cells were transfected with pCHA-TAF-Ib
and incubated for 48 h. Before collecting cells, cells were treated with 0.1 mM
of TSA for 0, 4, 12 and 20 h. ChIP assays were performed with indicated
antibodies. The HCMV minimal promoter region of the luciferase transgene
was amplified by PCR using immunoprecipitated DNA as template.
PCR products amplified by 23, 25, 27 and 29 PCR cycles (right of the
panel) were analyzed by a 6% polyacrylamide gel and visualized by staining
with EtBr. Input DNA was purified from 1/50 of cell lysates used for
immunoprecipitation.
712 Nucleic Acids Research, 2007, Vol. 35, No. 3function of TAF-I in this study, it is possible that our ﬁnding
on the TAF-I-mediated mechanism may be applicable to
transcription inhibition as well. Remodeling of the chromatin
structure by TAF-I might promote the binding of a repres-
sor(s) to the DNA, thereby repressing the transcription
independent of its INHAT function.
Why TAF-I does not play a role similar to that of INHAT
at the cTnC gene and the model gene promoters used in this
study remains to be determined. A current model of the
INHAT function indicates that TAF-I binds stably to nucleo-
somes and represses the access of HATs by masking the
N-terminal histone tail (19). However, we could not detect
stable TAF-I-nucleosome complexes in vitro and in vivo
(data not shown). We found that only chromatin from cells
cross-linked with formaldehyde, but not from naive cells,
co-immunoprecipitated with TAF-Ib (Figures 1D and 3B,
and data not shown). These results indicate the possibility
that association of TAF-I with chromatin is weak and/or
Figure 7. TAF-Ib binds to core histones and remodels the chromatin structure independent of acetylation and the N-terminal tail of histones. (A) Preparation of
hyperacetylated core histones. Core histones were purified HeLa cells incubated in the absence (lane 1) or presence of 10 mM of NaBu (lane 2). Core histones
were separated through a 15% SDS–PAGE and visualized by staining with CBB (upper panel). The histone acetylation level was examined by western blotting
using anti-acetylated histone H3 antibody (lower panel). (B) Immunoprecipitation assays. One microgram of core histones prepared from mock-treated cells
(N, lanes 1–4), hyperacetylated core histones prepared from NaBu-treated cells (Ac, lanes 5–7), and tail-less core histones (TL, lanes 8–10) were mixed with
bacterially expressed hexa-histidine (His)-tagged TAF-Ib (1 mg) in IP buffer [50 mM Tris–HCl (pH 7.9), 1 mM EDTA, 0.1% Triton X-100, 1 mM
phenylmethlysulfonyl fluoride (PMSF) and 10 mM NaBu] containing 150 mM NaCl and incubated at 4 C for 2 h. Protein complexes were immunoprecipitated
without (lane 1) or with (lanes 2–10) the anti-TAF-Ib antibody. Proteins bound to protein A-sepharose beads were separated through a 15% SDS–PAGE and
visualized by silver staining. Three hundreds nanograms of each core histone was loaded as Input (left panel). NaCl concentrations in the washing buffer are
indicated at the top of the lanes. (C) MNase digestion of reconstituted chromatin. The pUC119-ML2 DNA was assembled into chromatin using core histones
prepared from mock-treated cells (N), hyperacetylated core histones prepared from NaBu-treated cells (Ac), and tail-less core histones (TL) by the salt dialysis
method, respectively. Naked DNA (lanes 1–4) and reconstituted chromatin with core histones prepared from mock-treated cells (N-chromatin, lanes 5–7), and
hyperacetylated core histones prepared from NaBu-treated cells (Ac-chromatin, lanes 8–10), or tail-less core histones (TL-chromatin, lanes 11–13) were partially
digested without (lane 1) or with 0.01 U (lanes 2, 5, 8 and 11), 0.04 U (lanes 3, 6, 9 and 12), and 0.1 U (lanes 4, 7, 10 and 13) of MNase. Purified DNAs was
separated on 1.4% agarose gel electrophoresis and visualized by SYBR Gold staining. Lane M shows DNA size markers. (D) The diagram of the restriction sites
of the Ad ML promoter region on pUC119-ML2 plasmid DNA. The arrow shows the transcription initiation site of the ML gene. The arrowheads show the sites
of PvuII. The filled region shows the Ad DNA on pUC119 vector. Numbers represent the size of each DNA fragment generated by PvuII. The probe for Southern
blotting is indicated. (E) Restriction endonuclease sensitivity assays. Fifty nanogram of naked DNA (lanes 1–3) and reconstituted chromatins (50 ng DNA, N-
chromatin; lanes 4–7, Ac-chromatin; lanes 8–11, and TL-chromatin; lanes 12–15) were incubated without (lanes 1, 3–5, 8–9 and 12–13) or with His-tagged TAF-
Ib (0.5 mg for lanes 6, 10 and 14, and 1.5 mg for lanes 2, 7, 11 and 15) at 30 C for 30 min. The mixture was subjected to partial digestion without (lanes 1–2, 4, 8
and 12) or with PvuII (1 U, lanes 3, 5–7, 9–11 and 13–15) at 37 C for 5 min. DNAs were purified, separated by electrophoresis on a 1% agarose gel, and
subjected to Southern blotting followed by autoradiography. The probe for Southern blotting is shown in Figure 6D.
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Although TAF-I and chromatin cannot form a stable
complex, a transient contact of TAF-I with the nucleosomes
may be sufﬁcient to remodel the chromatin structure
(Figures 2E and 7E). However, this could be less effective
in remodeling and is not a gene-speciﬁc process. In fact,
the molecular number of the TAF-Ib dimer required for
remodeling was 5 to 15 times more than that of histones in
our in vitro chromatin remodeling assays (Figures 2E and
7E). It is possible that TAF-I alone cannot function efﬁciently
as a transcription stimulatory factor or INHAT in vivo.W e
hypothesize that other cellular factors/cofactors would
support the gene-speciﬁc function of TAF-I for recruiting
TAF-I on a speciﬁc gene locus and/or modulating the
function of TAF-I. Although TAF-IbDC3 could be associated
with the model gene promoter region, it was found to be
incapable of stimulating transcription in vivo (Figures 2C
and 3D) and remodeling the chromatin structure in vitro
(Figure 2E). These suggest that recruiting TAF-I on the
speciﬁc chromatin region could be dependent on proper
dimer formation and/or the resultant exposure of the hydro-
philic surface by dimer formation (10) rather than the interac-
tion between histones and the acidic cluster of TAF-I.
Further, it is interesting to hypothesize that the C-terminal
acidic cluster is a functional domain of TAF-Ib for the
chromatin remodeling, and the N-terminal region containing
the coiled-coil dimerization region with the hydrophilic
surface is a binding domain for the gene-speciﬁc factor to
recruit TAF-I on the chromatin. For example, THAP7, a
recently identiﬁed TAF-I interacting protein, recruits TAF-
Ib to a speciﬁc promoter and down-regulates the transcrip-
tional activity of the retinoic acid receptor and ER (46). It
is worthwhile to note that 120–225 amino acid residues
of TAF-Ib is essential for the binding to THAP7, and the
N-terminal region containing the coiled-coil region greatly
enhances this interaction, while the C-terminal acidic cluster
is dispensable (46). Fe65 behaves like an adaptor protein that
assembles TAF-I and Tip60 on the KAI1 gene chromatin, and
consequently stimulates its transcription (23). We demon-
strated that TAF-I may speciﬁcally targets MLL on certain
gene loci (22). In this sense, systematic identiﬁcation of
genes regulated by TAF-I and genomic regions associated
with TAF-I could be useful to obtain a cue. We propose
that transcriptome and interactome analyses can greatly
aid in the investigation and classiﬁcation of the gene regula-
tory roles for not only TAF-I and but also other histone
chaperones.
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